Workup for Suppressed TSH in Presumed Hypothyroidism
If you find a suppressed TSH in a patient you thought had hypothyroidism, you're likely dealing with levothyroxine over-replacement—immediately repeat the TSH with free T4 and total T3 or free T3 within 2-4 weeks, then reduce the levothyroxine dose to bring TSH back into the normal range.
Initial Diagnostic Steps
The finding of a suppressed TSH in "presumed hypothyroidism" indicates one of two scenarios:
1. Exogenous Subclinical Hyperthyroidism (Most Likely)
This patient is on levothyroxine and you've overdosed them. The workup is straightforward:
- Repeat TSH with free T4 and T3/free T3 within 2-4 weeks 1
- Review the indication for thyroid hormone therapy
- If TSH is 0.1-0.45 mIU/L: Decrease levothyroxine dose unless the patient has thyroid cancer or nodules requiring TSH suppression 1
- If TSH is <0.1 mIU/L: Definitely decrease levothyroxine dose to allow TSH to rise toward normal range 1
Critical caveat: If the patient has cardiac symptoms, atrial fibrillation, or arrhythmias, perform these tests within a shorter interval—don't wait the full 4 weeks 1.
2. Endogenous Subclinical Hyperthyroidism (Less Likely)
If the patient is NOT on levothyroxine, you've misdiagnosed them—they don't have hypothyroidism at all.
Workup algorithm based on TSH level:
TSH 0.1-0.45 mIU/L (Mildly Suppressed)
- Repeat TSH within 2 weeks if acute illness, medications, or other confounding factors are present 1
- If no confounders, repeat in 3 months 1
- If persistently low and patient has no cardiac disease: retest every 3-12 months until TSH normalizes or condition is stable 1
- Obtain radioactive iodine uptake and scan to determine etiology (Graves disease vs. nodular goiter vs. destructive thyroiditis) 1
TSH <0.1 mIU/L (Frankly Suppressed)
- Repeat TSH with free T4 and total T3 or free T3 within 4 weeks 1
- Shorter interval if cardiac symptoms present 1
- Obtain radioactive iodine uptake and scan to distinguish:
Key Pitfalls to Avoid
Don't assume the diagnosis is correct: A suppressed TSH contradicts hypothyroidism. Either the patient is over-replaced on levothyroxine, or they never had hypothyroidism in the first place 2.
Don't rush to treatment: Many conditions and drugs can transiently suppress TSH 2. Always confirm persistence before acting.
Don't ignore cardiovascular risk: Even mildly suppressed TSH (0.1-0.45 mIU/L) may increase cardiovascular mortality in elderly patients 1. Suppressed TSH <0.1 mIU/L is associated with atrial fibrillation, heart failure, and bone loss 3.
Don't forget to check medication compliance and interactions: In patients on levothyroxine with unexpectedly suppressed TSH, verify they're not taking extra doses or that absorption isn't enhanced 4.
Special Populations
Elderly patients (>60 years): More aggressive workup and consideration for treatment even with mildly suppressed TSH due to increased cardiovascular and bone risks 1.
Patients with thyroid cancer or nodules: TSH suppression may be intentional—verify target TSH with endocrinologist before adjusting 1.
Patients with known nodular thyroid disease: Special consideration needed as they may develop overt hyperthyroidism with iodine exposure (contrast agents) 1.